# The cost of multiple sclerosis drugs in the US and the pharmaceutical industry

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-cost-of-multiple-sclerosis-drugs-in-the-us-and-the-pharmaceutical-industry/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Daniel M. Hartung,Dennis Bourdette,Sharia M. Ahmed,Ruth H. Whitham |
| Citations | 263 |
| DOI | 10.1212/wnl.0000000000001608 |
| Fields | Economics, Econometrics and Finance,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://n.neurology.org/content/neurology/84/21/2185.full.pdf |
| OpenAlex ID | https://openalex.org/W2151516700 |
| PMID | 25911108 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Daniel M. Hartung](https://scholariq.org/researchers/daniel-m-hartung/)

## Paper journal

- [Neurology](https://scholariq.org/journals/neurology/)

## Paper primary topic

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)

## Paper topics

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.